Life sciences news

SOPHIA ANTIPOLIS, France – June 16, 2022 | CureVac N.V., a German biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), has announced on June 08th 2022 the acquisition of Frame Cancer Therapeutics (formerly Frame Pharmaceuticals), a startup company based in Netherlands focused on advanced genomics and bioinformatics to identify both unique and shared[…]

SOPHIA ANTIPOLIS, France – April 20, 2022 | During recent decades, biopharmaceuticals have gained considerable attention as revolutionary therapeutics and vaccine strategies, attempting to fulfil the high expectations of resolving serious health conditions. Regarding nucleic acids, mRNA-based technologies have been established as promising approaches in therapy and prevention of numerous diseases. mRNA’s great potential can[…]

SOPHIA ANTIPOLIS, France – July 07, 2021 | Natera was founded by Matthew Rabinowitz, Ph.D., and Jonathan Sheena, M. Eng, in 2004. This American company provides DNA testing across multiple clinical areas including women’s health, organ health, and oncology. This DNA testing, involving a noninvasive blood-based test, is carried out using its next-generation cfDNA technology[…]

SOPHIA ANTIPOLIS, France – February 01, 2021 | After three decades of research, mRNA-based vaccines have proven their safety and efficacy. They have finally reached the market, holding the promise to revolutionize the field. In December 2020, the FDA and EMA granted historic authorization to the first mRNA vaccine in the United States and in[…]